Impax Asset Management Group plc Reduces Holdings in Stericycle, Inc. (NASDAQ:SRCL)

Impax Asset Management Group plc decreased its stake in shares of Stericycle, Inc. (NASDAQ:SRCL - Free Report) by 51.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,406,625 shares of the business services provider's stock after selling 1,518,516 shares during the quarter. Impax Asset Management Group plc owned approximately 1.52% of Stericycle worth $85,196,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the stock. Capital Research Global Investors raised its holdings in Stericycle by 11.4% in the first quarter. Capital Research Global Investors now owns 6,667,911 shares of the business services provider's stock valued at $351,732,000 after acquiring an additional 679,974 shares in the last quarter. Earnest Partners LLC grew its stake in shares of Stericycle by 12.4% during the first quarter. Earnest Partners LLC now owns 2,460,020 shares of the business services provider's stock worth $129,766,000 after purchasing an additional 271,025 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Stericycle by 7.0% in the second quarter. Dimensional Fund Advisors LP now owns 2,171,659 shares of the business services provider's stock valued at $126,238,000 after buying an additional 142,814 shares in the last quarter. Pentwater Capital Management LP purchased a new stake in Stericycle during the 2nd quarter worth about $83,010,000. Finally, Magnetar Financial LLC acquired a new position in shares of Stericycle during the 2nd quarter worth about $81,596,000. Institutional investors and hedge funds own 98.82% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com initiated coverage on Stericycle in a report on Monday. They issued a "hold" rating for the company. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $74.00.

Stericycle Price Performance

NASDAQ:SRCL remained flat at $61.98 during mid-day trading on Tuesday. The stock has a market capitalization of $5.75 billion, a P/E ratio of 163.11, a price-to-earnings-growth ratio of 3.38 and a beta of 1.10. Stericycle, Inc. has a 52 week low of $37.78 and a 52 week high of $61.99. The firm's 50 day moving average price is $60.89 and its 200-day moving average price is $56.91. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 0.55.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.